IRESSA® (gefitinib) Approved by the U.S. Food and Drug Administration for First-Line Treatment of Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer

… Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer AstraZeneca today announced that the … patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal … the Rotor-Gene Q MDx. About Lung Cancer Lung cancer is the leading cause of …